Mariana Farraia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mariana Farraia has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- João Cavaleiro Rufo
University of Porto
20 shared publications - Inês Paciência
Center for Environmental and Respiratory Health Research (CERH), Population Health University of Oulu Oulu Finland
18 shared publications - Francisca Castro Mendes
EPIUnit‐Institute of Public Health University of Porto Porto Portugal
17 shared publications - Luís Delgado
Basic and Clinical Immunology, Department of Pathology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
14 shared publications - André Moreira
Basic and Clinical Immunology Unit, Department of Pathology, Faculty of Medicine University of Porto Porto Portugal
13 shared publications - Pedro Moreira
Faculty of Nutrition and Food Sciences, University of Porto, Porto, Portugal
9 shared publications
Latest Publications
- 7 July 2026
- Published by Taylor & Francis in Future Oncology
- Vol. 22 (18) , 2143-2154
Transportability of tislelizumab trial outcomes from RATIONALE-315, RATIONALE-303, and RATIONALE-312 to the European population in early-stage non-small cell lung cancer (NSCLC), advanced NSCLC and extensive-stage small cell lung cancer (ES-SCLC)
1. Lung cancer is a global health concern with high incidence and mortality rates. In 2022, it was the most frequently diagnosed cancer, with 2.5 million new cases, representing 12.4% of all cancer...
- 7 July 2026
- Published by Taylor & Francis in Future Oncology
- Vol. 22 (18) , 2143-2154
Transportability of tislelizumab trial outcomes from RATIONALE-315, RATIONALE-303, and RATIONALE-312 to the European population in early-stage non-small cell lung cancer (NSCLC), advanced NSCLC and extensive-stage small cell lung cancer (ES-SCLC)
1. Lung cancer is a global health concern with high incidence and mortality rates. In 2022, it was the most frequently diagnosed cancer, with 2.5 million new cases, representing 12.4% of all cancer...
- 10 December 2023
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 34 (12) , e14056
Component‐resolved diagnosis in childhood and prediction of asthma in early adolescence: A birth cohort study
Introduction: Component‐resolved diagnosis (CRD) has been decisive in exploring the mechanisms of IgE sensitization, but the predictive ability to detect asthma has not been addressed. We aim to develop and evaluate the performance of a personalized predictive algorithm for asthma that integrates information on allergic sensitization using CRD.Methods: One thousand one hundred one twenty‐five children from the Generation XXI birth cohort were randomly selected to perform a screening test for allergic sensitization and a subsample was characterized using CRD against 112 allergen components. Allergen components were analyzed using volcano plots and partial least squares (PLS) analysis. Logistic regression was performed to assess the associations between the obtained latent components (LC) and allergic outcomes (asthma, rhinitis, eczema) including other potential predictors used in previous asthma risk scores. The accuracy of the model in predicting asthma was assessed using Receiver Operating Characteristic (ROC) curve statistics.Results: In the PLS, the first LC was positively associated with asthma, rhinitis, and eczema. This LC was mainly driven by positive weights for Der p 1/2/23, Der f 1/2, and Fel d 1. The main components in the second LC were pollen and food allergens. History of early wheezing and parental allergy were included in the predictive model and the area under the curve improved to 0.82.Conclusions: This is the first approach to improve the clinical applicability of CRD by combining CRD and clinical data to predict asthma at 13 years. Sensitization to distinct allergen molecules seems relevant to improve the accuracy of asthma prediction models.
- 10 December 2023
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 34 (12) , e14056
Component‐resolved diagnosis in childhood and prediction of asthma in early adolescence: A birth cohort study
Introduction: Component‐resolved diagnosis (CRD) has been decisive in exploring the mechanisms of IgE sensitization, but the predictive ability to detect asthma has not been addressed. We aim to develop and evaluate the performance of a personalized predictive algorithm for asthma that integrates information on allergic sensitization using CRD.Methods: One thousand one hundred one twenty‐five children from the Generation XXI birth cohort were randomly selected to perform a screening test for allergic sensitization and a subsample was characterized using CRD against 112 allergen components. Allergen components were analyzed using volcano plots and partial least squares (PLS) analysis. Logistic regression was performed to assess the associations between the obtained latent components (LC) and allergic outcomes (asthma, rhinitis, eczema) including other potential predictors used in previous asthma risk scores. The accuracy of the model in predicting asthma was assessed using Receiver Operating Characteristic (ROC) curve statistics.Results: In the PLS, the first LC was positively associated with asthma, rhinitis, and eczema. This LC was mainly driven by positive weights for Der p 1/2/23, Der f 1/2, and Fel d 1. The main components in the second LC were pollen and food allergens. History of early wheezing and parental allergy were included in the predictive model and the area under the curve improved to 0.82.Conclusions: This is the first approach to improve the clinical applicability of CRD by combining CRD and clinical data to predict asthma at 13 years. Sensitization to distinct allergen molecules seems relevant to improve the accuracy of asthma prediction models.
- Open Access
- 1 September 2023
- Published by Edra SpA in European Annals of Allergy and Clinical Immunology
- Vol. 55 (05) , 212-228
Cost-effectiveness analysis of grass pollen specific immunotherapy in children with allergic rhinitis compared to the standard of care symptomatic treatment in Portugal
M. Farraia 123 I. Paci?ncia 12 F. Castro Mendes 123 J. Cavaleiro Rufo 12 L. Delgado 34 A. Moreira mariana.farraia@gmail.com 1235 M. Farraia 123 I....
- 1 September 2023
- Published by Edra SpA in European Annals of Allergy and Clinical Immunology
- Vol. 55 (05) , 212-228
Open AccessCost-effectiveness analysis of grass pollen specific immunotherapy in children with allergic rhinitis compared to the standard of care symptomatic treatment in Portugal
M. Farraia 123 I. Paci?ncia 12 F. Castro Mendes 123 J. Cavaleiro Rufo 12 L. Delgado 34 A. Moreira mariana.farraia@gmail.com 1235 M. Farraia 123 I....
- 2 June 2023
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 34 (6) , e13963
Sensitization trajectories to multiple allergen components in a population‐based birth‐cohort
Background: The characteristics of allergic sensitization profiles can differ between populations and geographic regions, contributing differently to the association with allergic diseases. Consequently, the sensitization trajectories found in previous studies conducted in Northern Europe may not apply in Southern European countries.Objective: To identify trajectories of allergic sensitization profiles during childhood and evaluate the association with allergic outcomes, using data from a Portuguese birth cohort.Methods: A random sample from Generation XXI was screened for allergic sensitization at 10 years of age. Among 452 allergic sensitized children, 186 were tested with ImmunoCAP™ ISAC multiplex array that detects 112 molecular components, at three follow‐ups (4, 7, and 10 years old). Information on allergic outcomes (asthma, rhinitis, atopic dermatitis) was obtained at the 13‐year‐old follow‐up. Latent class analysis (LCA) was used to identify clusters of participants with similar sensitization profiles. Then, sensitization trajectories were defined based on the most prevalent transitions between clusters over time. Logistic regression was applied to estimate the association between sensitization trajectories and allergic diseases.Results: Five trajectories were proposed: “no/few sensitizations,” “early persistent house dust mites (HDM),” “early HDM and persistent/late grass pollen,” “late grass pollen,” and “late HDM.” The “early HDM and persistent/late grass pollen” trajectory was associated with rhinitis and “early persistent HDM” with asthma and rhinitis.Conclusion: Distinct sensitization trajectories pose different risks in the development of allergic diseases. These trajectories present some differences from those in Northern European countries and are important for planning adequate prevention health plans.
- 2 June 2023
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 34 (6) , e13963
Sensitization trajectories to multiple allergen components in a population‐based birth‐cohort
Background: The characteristics of allergic sensitization profiles can differ between populations and geographic regions, contributing differently to the association with allergic diseases. Consequently, the sensitization trajectories found in previous studies conducted in Northern Europe may not apply in Southern European countries.Objective: To identify trajectories of allergic sensitization profiles during childhood and evaluate the association with allergic outcomes, using data from a Portuguese birth cohort.Methods: A random sample from Generation XXI was screened for allergic sensitization at 10 years of age. Among 452 allergic sensitized children, 186 were tested with ImmunoCAP™ ISAC multiplex array that detects 112 molecular components, at three follow‐ups (4, 7, and 10 years old). Information on allergic outcomes (asthma, rhinitis, atopic dermatitis) was obtained at the 13‐year‐old follow‐up. Latent class analysis (LCA) was used to identify clusters of participants with similar sensitization profiles. Then, sensitization trajectories were defined based on the most prevalent transitions between clusters over time. Logistic regression was applied to estimate the association between sensitization trajectories and allergic diseases.Results: Five trajectories were proposed: “no/few sensitizations,” “early persistent house dust mites (HDM),” “early HDM and persistent/late grass pollen,” “late grass pollen,” and “late HDM.” The “early HDM and persistent/late grass pollen” trajectory was associated with rhinitis and “early persistent HDM” with asthma and rhinitis.Conclusion: Distinct sensitization trajectories pose different risks in the development of allergic diseases. These trajectories present some differences from those in Northern European countries and are important for planning adequate prevention health plans.
- Open Access
- 14 December 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (24) , 16799
The Effect of Fire Smoke Exposure on Firefighters’ Lung Function: A Meta-Analysis
Firefighters are exposed to a range of harmful substances during firefighting. Exposure to fire smoke has been associated with a decrease in their lung function. However, the cause–effect relationship between those two factors is not yet demonstrated. This meta-analysis aimed to evaluate the potential associations between firefighters’ occupational exposure and their lung function deterioration. Studies were identified from PubMed, Web of Science, Scopus and Science Direct databases (August 1990–March 2021). The studies were included when reporting the lung function values of Forced Expiratory Volume in 1 s (FEV1) or Forced Vital Capacity (FVC). The meta-analyses were performed using the generic inverse variance in R software with a random-effects model. Subgroup analysis was used to determine if the lung function was influenced by a potential study effect or by the participants’ characteristics. A total of 5562 participants from 24 studies were included. No significant difference was found between firefighters’ predicted FEV1 from wildland, 97.64% (95% CI: 91.45–103.82%; I2 = 99%), and urban fires, 99.71% (95% CI: 96.75–102.67%; I2 = 98%). Similar results were found for the predicted FVC. Nevertheless, the mean values of firefighters’ predicted lung function varied significantly among studies, suggesting many confounders, such as trials’ design, statistical methods, methodologies applied, firefighters’ daily exposure and career length, hindering an appropriate comparison between the studies.
- 14 December 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (24) , 16799
Open AccessThe Effect of Fire Smoke Exposure on Firefighters’ Lung Function: A Meta-Analysis
Firefighters are exposed to a range of harmful substances during firefighting. Exposure to fire smoke has been associated with a decrease in their lung function. However, the cause–effect relationship between those two factors is not yet demonstrated. This meta-analysis aimed to evaluate the potential associations between firefighters’ occupational exposure and their lung function deterioration. Studies were identified from PubMed, Web of Science, Scopus and Science Direct databases (August 1990–March 2021). The studies were included when reporting the lung function values of Forced Expiratory Volume in 1 s (FEV1) or Forced Vital Capacity (FVC). The meta-analyses were performed using the generic inverse variance in R software with a random-effects model. Subgroup analysis was used to determine if the lung function was influenced by a potential study effect or by the participants’ characteristics. A total of 5562 participants from 24 studies were included. No significant difference was found between firefighters’ predicted FEV1 from wildland, 97.64% (95% CI: 91.45–103.82%; I2 = 99%), and urban fires, 99.71% (95% CI: 96.75–102.67%; I2 = 98%). Similar results were found for the predicted FVC. Nevertheless, the mean values of firefighters’ predicted lung function varied significantly among studies, suggesting many confounders, such as trials’ design, statistical methods, methodologies applied, firefighters’ daily exposure and career length, hindering an appropriate comparison between the studies.
- Open Access
- 1 November 2022
- Published by Wolters Kluwer Health in Porto Biomedical Journal
- Vol. 7 (6) , e188
Diagnosis of pathological conditions through electronic nose analysis of urine samples: a systematic review and meta-analysis
Currently available urinalysis methods are often applied for screening and monitoring of several pathologies. However, traditionally analyzed biomarkers in urinalysis still lack sensitivity and specificity to accurately diagnose some diseases. Several studies have proposed the use of electronic noses (eNoses) for the analysis of volatile organic compounds in urine samples that may, directly or indirectly, correlate with certain pathologies. Hence, the aim of this study was to perform a systematic review and meta-analysis of studies concerning the use of portable electronic noses for diagnosis or monitoring of pathologies through analysis of urine samples. A systematic review of the literature was held according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Twenty-four articles met the inclusion criteria and were included in the analysis. The results of the revised studies showed that there are various volatile organic compound profiles, identified through eNose analysis, that may be applied for diagnosis or monitoring of several diseases, such as diabetes, urinary tract infection, inflammatory bowel disease, and kidney disease. A meta-analysis was conducted taking into consideration the data of 10 of the initial 24 articles. The pooled sensitivity, specificity, and diagnostic odds ratio were 84% (95% CI, 0.72–0.92), 85% (95% CI, 0.75–0.91), and 24.17 (95% CI: 7.85–74.41), respectively. The area under the receiver operating characteristic curve was 0.897. These results suggest that eNose technology has adequate diagnostic accuracy for several pathologies and could be a promising screening tool for clinical settings. However, more studies are needed to reduce heterogeneity between results.
- 1 November 2022
- Published by Wolters Kluwer Health in Porto Biomedical Journal
- Vol. 7 (6) , e188
Open AccessDiagnosis of pathological conditions through electronic nose analysis of urine samples: a systematic review and meta-analysis
Currently available urinalysis methods are often applied for screening and monitoring of several pathologies. However, traditionally analyzed biomarkers in urinalysis still lack sensitivity and specificity to accurately diagnose some diseases. Several studies have proposed the use of electronic noses (eNoses) for the analysis of volatile organic compounds in urine samples that may, directly or indirectly, correlate with certain pathologies. Hence, the aim of this study was to perform a systematic review and meta-analysis of studies concerning the use of portable electronic noses for diagnosis or monitoring of pathologies through analysis of urine samples. A systematic review of the literature was held according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Twenty-four articles met the inclusion criteria and were included in the analysis. The results of the revised studies showed that there are various volatile organic compound profiles, identified through eNose analysis, that may be applied for diagnosis or monitoring of several diseases, such as diabetes, urinary tract infection, inflammatory bowel disease, and kidney disease. A meta-analysis was conducted taking into consideration the data of 10 of the initial 24 articles. The pooled sensitivity, specificity, and diagnostic odds ratio were 84% (95% CI, 0.72–0.92), 85% (95% CI, 0.75–0.91), and 24.17 (95% CI: 7.85–74.41), respectively. The area under the receiver operating characteristic curve was 0.897. These results suggest that eNose technology has adequate diagnostic accuracy for several pathologies and could be a promising screening tool for clinical settings. However, more studies are needed to reduce heterogeneity between results.
Cost‐effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma
Background: Cost‐effectiveness studies evaluating allergen immunotherapy (AIT) in children are limited but needed to drive clinical and policy‐making decisions such as reimbursement of new interventions. In this study, we compared the cost effectiveness of subcutaneous (SCIT) and sublingual immunotherapy (SLIT) tablets to the standard of care (SOC) treatment in children with house dust mite‐driven (HDM) allergic asthma.Methods: We developed a hypothetical Markov model based on the Global Initiative for Asthma (GINA) severity steps to compare the three strategies over a 10‐year horizon divided by cycles of 6 months. SOC was used as a reference to calculate the incremental cost‐effectiveness ratio (ICER). Deterministic and probabilistic sensitivity analyses were used to assess models’ uncertainty. Other scenarios were evaluated to strengthen the presentation of results.Results: The ICER for SCIT and SLIT tablets was 1281€ and 7717€, respectively. The cost‐effectiveness threshold for Portugal was 18,482.80€; both treatment approaches were below this limit. The major contributors to these results were the AIT effects on reducing moderate and severe exacerbations and asthma controller medication. In the sensitivity analysis, SCIT revealed a higher probability of cost‐effectiveness than SLIT. When including allergic rhinitis as comorbidity, ICER values reduced markedly, especially for SCIT intervention.Conclusions: AIT was cost effective in children with HDM‐driven allergic asthma, especially when given by the subcutaneous route. The high probability of cost effectiveness, especially for SCIT, may drive future policy decisions and AIT‐prescribing habits. AIT adherence greatly influenced the results highlighting the value of implementing strategies to promote adherence rates.
Cost‐effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma
Background: Cost‐effectiveness studies evaluating allergen immunotherapy (AIT) in children are limited but needed to drive clinical and policy‐making decisions such as reimbursement of new interventions. In this study, we compared the cost effectiveness of subcutaneous (SCIT) and sublingual immunotherapy (SLIT) tablets to the standard of care (SOC) treatment in children with house dust mite‐driven (HDM) allergic asthma.Methods: We developed a hypothetical Markov model based on the Global Initiative for Asthma (GINA) severity steps to compare the three strategies over a 10‐year horizon divided by cycles of 6 months. SOC was used as a reference to calculate the incremental cost‐effectiveness ratio (ICER). Deterministic and probabilistic sensitivity analyses were used to assess models’ uncertainty. Other scenarios were evaluated to strengthen the presentation of results.Results: The ICER for SCIT and SLIT tablets was 1281€ and 7717€, respectively. The cost‐effectiveness threshold for Portugal was 18,482.80€; both treatment approaches were below this limit. The major contributors to these results were the AIT effects on reducing moderate and severe exacerbations and asthma controller medication. In the sensitivity analysis, SCIT revealed a higher probability of cost‐effectiveness than SLIT. When including allergic rhinitis as comorbidity, ICER values reduced markedly, especially for SCIT intervention.Conclusions: AIT was cost effective in children with HDM‐driven allergic asthma, especially when given by the subcutaneous route. The high probability of cost effectiveness, especially for SCIT, may drive future policy decisions and AIT‐prescribing habits. AIT adherence greatly influenced the results highlighting the value of implementing strategies to promote adherence rates.
Allergen immunotherapy for asthma prevention: A systematic review and meta‐analysis of randomized and non‐randomized controlled studies
Background: Allergen immunotherapy (AIT) is a disease‐modifying treatment for IgE‐mediated diseases. Randomized controlled trials (RCTs) support AIT's potential role in asthma prevention but evidence from non‐randomized studies of interventions (NRSI) and longitudinal observational studies has been poorly addressed. Therefore, we aimed to conduct a systematic review and meta‐analysis to assess clinical data from all study types to evaluate quantitatively the preventive role of AIT in asthma onset.Methods: We search three databases. Studies were screened, selected and evaluated for quality using risk‐of‐bias (ROB) tools. Data were descriptively summarized and meta‐analysed using random effects. We performed a sensitivity, influence and subgroup analyses. Publication bias and heterogeneity were assessed.Results: From the 4549 identified studies, 24 (12 RCTs and 12 NRSI) were included in the qualitative synthesis and 18 underwent meta‐analysis. One study was at low ROB, seven had moderate ROB, and 15 were proven of high ROB. Random‐effects analysis showed a significant decrease in the risk of developing asthma following AIT by 25% (RR, 95% CI: 0.75, 0.64–0.88). This effect was not significant in the sensitivity analysis. Publication bias raised concerns, together with the moderate heterogeneity between studies (I2 = 58%). Subgroup analysis showed a remarkable preventive effect of AIT in children (RR, 95% CI: 0.71, 0.53–0.96), when completing 3 years of therapy (RR, 95% CI: 0.64, 0.47–0.88), and in mono‐sensitized patients (RR, 95% CI: 0.49, 0.39–0.61).Conclusions: Our findings support a possible preventive effect of AIT in asthma onset and suggest an enhanced effect when administered in children, mono‐sensitized, and for at least 3 years, independently of allergen type.
Allergen immunotherapy for asthma prevention: A systematic review and meta‐analysis of randomized and non‐randomized controlled studies
Background: Allergen immunotherapy (AIT) is a disease‐modifying treatment for IgE‐mediated diseases. Randomized controlled trials (RCTs) support AIT's potential role in asthma prevention but evidence from non‐randomized studies of interventions (NRSI) and longitudinal observational studies has been poorly addressed. Therefore, we aimed to conduct a systematic review and meta‐analysis to assess clinical data from all study types to evaluate quantitatively the preventive role of AIT in asthma onset.Methods: We search three databases. Studies were screened, selected and evaluated for quality using risk‐of‐bias (ROB) tools. Data were descriptively summarized and meta‐analysed using random effects. We performed a sensitivity, influence and subgroup analyses. Publication bias and heterogeneity were assessed.Results: From the 4549 identified studies, 24 (12 RCTs and 12 NRSI) were included in the qualitative synthesis and 18 underwent meta‐analysis. One study was at low ROB, seven had moderate ROB, and 15 were proven of high ROB. Random‐effects analysis showed a significant decrease in the risk of developing asthma following AIT by 25% (RR, 95% CI: 0.75, 0.64–0.88). This effect was not significant in the sensitivity analysis. Publication bias raised concerns, together with the moderate heterogeneity between studies (I2 = 58%). Subgroup analysis showed a remarkable preventive effect of AIT in children (RR, 95% CI: 0.71, 0.53–0.96), when completing 3 years of therapy (RR, 95% CI: 0.64, 0.47–0.88), and in mono‐sensitized patients (RR, 95% CI: 0.49, 0.39–0.61).Conclusions: Our findings support a possible preventive effect of AIT in asthma onset and suggest an enhanced effect when administered in children, mono‐sensitized, and for at least 3 years, independently of allergen type.
- 20 September 2021
- Published by Publicacoes Ciencia e Vida, Lda in Revista Portuguesa de Imunoalergologia
- Vol. 29 (3) , 159-166
Associações entre a exposição a espaços verdes e o desenvolvimento de asma e doença alérgica em ambientes urbanos: Da coerência à controvérsia científica
A exposição ao ambiente urbano tem sido associada ao desenvolvimento de asma e doença alérgica. No entanto, as associações encontradas ainda geram controvérsia, com alguns estudos a indicarem os espaços verdes como protetores no desenvolvimento das doenças alérgicas, enquanto outros apontam essas exposições como tendo um papel indutor na exacerbação da sintomatologia associada. O presente artigo pretende rever a evidência científica até aqui publicada, de forma a debater o eventual efeito da exposição a espaços verdes urbanos no desenvolvimento de asma e doença alérgica em crianças, com especial importância dada aos estudos realizados em Portugal.
- 20 September 2021
- Published by Publicacoes Ciencia e Vida, Lda in Revista Portuguesa de Imunoalergologia
- Vol. 29 (3) , 159-166
Associações entre a exposição a espaços verdes e o desenvolvimento de asma e doença alérgica em ambientes urbanos: Da coerência à controvérsia científica
A exposição ao ambiente urbano tem sido associada ao desenvolvimento de asma e doença alérgica. No entanto, as associações encontradas ainda geram controvérsia, com alguns estudos a indicarem os espaços verdes como protetores no desenvolvimento das doenças alérgicas, enquanto outros apontam essas exposições como tendo um papel indutor na exacerbação da sintomatologia associada. O presente artigo pretende rever a evidência científica até aqui publicada, de forma a debater o eventual efeito da exposição a espaços verdes urbanos no desenvolvimento de asma e doença alérgica em crianças, com especial importância dada aos estudos realizados em Portugal.
- Open Access
Increasing Vegetable Diversity Consumption Impacts the Sympathetic Nervous System Activity in School-Aged Children
Evidence about the impact of vegetable and fruit diversity consumption on the autonomic nervous system (ANS) functioning is scarce. In this cross-sectional study (513 participants, 49.9% girls aged 7 to 12 years), we evaluated the association between vegetable and fruit diversity consumption and the ANS in school-aged children. Dietary intake was collected using a single 24-h recall questionnaire. Fruit and vegetable diversity consumption was estimated by summing up all the different individual vegetables and fruits consumed in one day. Pupillometry was used to assess pupillary light response, which evaluated the ANS activity. Adjusted linear regressions estimated the association between vegetable and fruit diversity consumption with pupillary light response measures. There was a positive and significant association between vegetable diversity consumption and the average dilation velocity, a measure related to the sympathetic nervous system activity (β-coefficient = 0.03, 95%CI: 0.002; 0.07). Our findings show that vegetable diversity consumption is associated with the ANS response, a possible early link between diet and health in school-aged children.
Open AccessIncreasing Vegetable Diversity Consumption Impacts the Sympathetic Nervous System Activity in School-Aged Children
Evidence about the impact of vegetable and fruit diversity consumption on the autonomic nervous system (ANS) functioning is scarce. In this cross-sectional study (513 participants, 49.9% girls aged 7 to 12 years), we evaluated the association between vegetable and fruit diversity consumption and the ANS in school-aged children. Dietary intake was collected using a single 24-h recall questionnaire. Fruit and vegetable diversity consumption was estimated by summing up all the different individual vegetables and fruits consumed in one day. Pupillometry was used to assess pupillary light response, which evaluated the ANS activity. Adjusted linear regressions estimated the association between vegetable and fruit diversity consumption with pupillary light response measures. There was a positive and significant association between vegetable diversity consumption and the average dilation velocity, a measure related to the sympathetic nervous system activity (β-coefficient = 0.03, 95%CI: 0.002; 0.07). Our findings show that vegetable diversity consumption is associated with the ANS response, a possible early link between diet and health in school-aged children.